Moclobemide: a reversible inhibitor of monoamine oxidase type A.
The search for the ideal antidepressant continues. Moclobemide, the first reversible inhibitor of monoamine oxidase type A to enter widespread clinical use, has a number of advantages over traditional monoamine oxidase inhibitors and represents a valuable addition to the antidepressant armamentarium.
Baldwin
D
D
Ealing Hospital, Middlesex.
Rudge
S
S
D001549:Benzamides / Q000009:adverse effects / Q000378:metabolism; D003866:Depressive Disorder / Q000188:drug therapy; D004347:Drug Interactions; D006801:Humans; D020912:Moclobemide; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000378:metabolism
D001549:Benzamides; D008996:Monoamine Oxidase Inhibitors; D020912:Moclobemide